China Resources Medical Holdings Company Limited (1PH) — Cash Flow Reinvestment Rate
China Resources Medical Holdings Company Limited (1PH) has a Cash Flow Reinvestment Rate of 0.57x as of June 2023, reinvesting €155.33 Million (capex €96.85 Million plus investments €58.49 Million) from operating cash flow of €270.22 Million. Check China Resources Medical Holdings Company (1PH) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Medical Holdings Company Limited Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for China Resources Medical Holdings Company Limited across 9 annual periods. Explore cash flow to debt ratio of China Resources Medical Holdings Company to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for China Resources Medical Holdings Company Limited (2016–2024)
Year-by-year capital reinvestment analysis for China Resources Medical Holdings Company Limited. For live market cap and broader valuation context, see 1PH company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.44x | €564.75 Million | €1.27 Billion | €563.69 Million | ▼ -61.2% |
| 2023 | 1.15x | €1.37 Billion | €1.20 Billion | €486.68 Million | ▲ +131.4% |
| 2022 | 0.50x | €310.21 Million | €626.58 Million | €252.87 Million | ▼ -72.8% |
| 2021 | 1.82x | €1.29 Billion | €710.43 Million | €198.43 Million | ▲ +216.8% |
| 2020 | 0.58x | €370.34 Million | €643.69 Million | €209.55 Million | ▲ +21.9% |
| 2019 | 0.47x | €172.73 Million | €366.05 Million | €36.37 Million | ▼ -61.1% |
| 2018 | 1.21x | €405.67 Million | €334.15 Million | €57.61 Million | ▼ -6.6% |
| 2017 | 1.30x | €597.53 Million | €459.54 Million | €34.50 Million | ▲ +78.7% |
| 2016 | 0.73x | €162.86 Million | €223.79 Million | €42.45 Million | — |